Clinical Study
MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
Table 2
Expression levels of miR-429 and AFB1 exposure levels and tumor size of cases.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Adjusted by age, sex, race, HBV and HCV infection status, and smoking and drinking status. |